| Application no. and date | 08732818.3 (espacenet) (Federated) (European Patent Register), 20080326 | | Patent/reg. no. and date | DK/EP 2203462, 20140521 | | Publication date | 20100707 | | Priority no. and date | US 909315 P, 20070330, US 982309 P, 20071024, US 53015, 20080321 | | EP pub. no. and date |
EP 2203462 20100707 | | Effective date | | | Applicant/owner | Gilead Pharmasset LLC, Gilead Sciences, Inc.
333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | PN813970DKQ | | Inventor | NAGARATHNAM, Dhanapalan, 52 Virginia Rail Drive
Bethany, CT 06524, US,
WANG, Peiyuan, 20 Radburn Road
Glenrock, NJ 07452, US,
DU, Jinfa, 1206 Reins Circle
New Hope, PA 18938, US,
SOFIA, Michael, Joseph, 3066 Antler Road
Doylestown, PA 18902, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | A61K 31/7064 (2006.01) , A61K 31/7076 (2006.01) | | Title | NUKLEOSID-PHOSPHORAMIDAT-PRODRUGS | | Int. application no. | US2008058183 | | Int. publication no. | WO2008121634 | | Related patent (certificate) | CA 2014 00061 | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
